newsfilter
← Latest News
GlobeNewswire·

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

DURHAM, N.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE:PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs ("Pelthos"), will